MJFF Announces $2-Million Funding Commitment to Drive Development of Parkinson's Disease Biomarker Pipeline
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
The Foundation has been a field leader in the development of PD biomarkers for several years. Approximately $9 million in MJFF investment to date has resulted in the emergence of several lead biomarker candidates. Today’s additional $2 million, directed toward biomarker discovery, underscores that commitment. Biomarkers 2009 will prioritize continued development of two separate types of biomarkers, both of major importance to PD therapeutics development: disease biomarkers and drug biomarkers.
0 Comments
View Comments
- Companies:
- Michael J. Fox Foundation
Related Content
Comments